MedCredits Token Sale

MedCredits Token Sale

Created using Figma
MedCredits is a blockchain-powered platform connecting patients and doctors worldwide on a decentralized healthcare network. The first software release 'Hippocrates' will connect patients to dermatologists for fast diagnoses at a fraction of the cost.
Mar 1, 2018
Apr 15, 2018
100% completed
Raised funds - no Data
past
Oct 17, 2017
Nov 30, 2017
100% completed
Raised funds - no Data
Goal 30 000 000.00 USD
past
Token Details
Ticker
MEDX
Company Details
Registered Country
United States
Additional Details
Platform
Ethereum
KYC
Yes
Categories
Platform, Health

About MedCredits Token Sale

Telemedicine and eHealth are poised for tremendous growth over the next decade.

  1. The ubiquity of smartphones now allows people to communicate both in writing and photographically with anyone in the world instantaneously.
  2. Telemedicine is beginning to find its place in medical fields heavily dependent on observational exam findings. Dermatology is one such field, whereby the diagnosis can often be confidently ascertained with photographs and a brief description.
  3. Despite the progress of telemedicine, it still faces many challenges associated with centralization, such as international payment, middlemen fees, patient anonymity, liability and regulation. For the first time in history, digital currencies with smart contract functionality have been integrated with peer-to-peer (P2P) networks to create decentralized platforms.

To date, we do not know of a medical application that uses a decentralized platform for health services. We believe that dermatology is the most readily accessible medical specialty to establish ourselves in blockchain-based telemedicine. Once established in teledermatology, we will strategically add medical specialties to build a thriving platform for patients and doctors.

This will serve as the foundation of a decentralized global electronic health record system. The final product will be both a global electronic health records system and marketplace giving patients instantaneous access to medical care anywhere in the world—that is, a truly free global healthcare market.

Features

-Snap a photo of skin problem
-Receive a diagnosis and medical recommendation

MedCredits Token Sale Roadmap

  • December 2016

  • - Inception of MedCredits as a worldwide marketplace for telemedicine services
  • March 2017

  • - Market analysis of telemedicine
    - Exploration of technological and institutional limitations of current telemedicine services
  • August 2017

  • - MedCredits, Inc. registered as a Delaware C corporation
    - White paper released
    - Legal consultation
    - Recruitment of licensed US dermatologists to guide Hippocrates development
  • September 2017

  • - Productive Edge adds MedCredits to its Blockchain Incubator
  • Read More
  • November 2017

  • - MEDX Seed Round opens to qualifying buyers
  • January 2018

  • - Demo Hippocrates dermatological application
    - Release of proof-of-concept
  • February 2018

  • - MEDX pre-sale opens
    - MEDX public sale opens
    - Hippocrates Alpha Release
    - Access to the alpha version will be by invitation-only to select token sale participants. Launch of alpha software on the main network after testing and debugging.
  • Q2 2018

  • - Hippocrates Beta Release
    - Physician onboarding
    - The MedCredits mobile and desktop platforms will be available to the general public. The app will be free for patient use for the first 6 months or 1000 cases. Physician compensation will come from the reserved MEDX dedicated to marketing.
  • Q4 2018

  • - Galen Alpha Release
    - Galen will expand the MedCredits platform to include mental health, internal medicine and “Ask-a-Doctor” feature. HIPPA-compliant video capabilities will be added to the platform for services requiring live video consultation.
  • Q1 2019

  • - Galen Beta Release
    - Physician onboarding
    - Stable release of Galen app and successful upgrade of the MedCredits platform. Begin marketing campaign in added medical specialties and general medicine.
  • Q4 2019

  • - Herophilus Release
    - Platform upgrade to include the following new features: patient charts, appointment scheduling, notifications of upcoming appointments and physician referral. The platform will now serve as both an EMR and health services platform, all in one location.

MedCredits Token Sale Team

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Sergey Ilin
Solidity Developer
unverified
Shane Van Coller
Solidity Developer
unverified
Evan Roth
Developer
unverified
Aagam Shah
Developer
unverified
Joseph Todaro
Business Development
unverified
Moshe Praver, Md
COO
unverified
James M Todaro, Md
CEO
unverified
John Todaro
Financial Officer
unverified
Ryan Cody
Technology Lead
unverified
Arjun Dupati, Md
Clinical Specialist
unverified
Vimell Yuvarajah
Developer
unverified
David Barmherzig
Developer
unverified
Paul Horvath
Cyber Security and Cryptography Expert
unverified

Advisors

Verified 0%

Attention. There is a risk that unverified members are not actually members of the team

Matt Hunter
Advisor
unverified

3 ICO

$13 010 415

Timothy Enneking
Advisor
unverified
Dr. Asa Marokus
Advisor
unverified
Stewart Donnell
Advisor
unverified

MedCredits Token Sale Last News

N/A
5.0 16
ICO Profile Vision Activity Potential Product Team

MedCredits Token Sale Reviews

bitcoinexchangeguide.com
reviews

MedCredits is a blockchain-based technology platform catered towards the world of medicine. The platform plans to change the way doctors and patients interact. So far, the company has already developed an app called Hippocrates where patients can receive a diagnosis from a dermatologist over their smartphone.

In the future, MedCredits plans to introduce DAOs for medical insurance and other products. They’re preparing for their ICO in September, which will see the release of MEDX tokens. The tokens will be used to participate in the MedCredits ecosystem.

Read More
  • Due to potential time differences in information updates, please verify the accuracy of each ICO project through its official website or other official communication channels.
  • This information is not intended as a recommendation or suggestion for ICO investment. Please conduct thorough research on the relevant information and make your own informed decision regarding ICO participation.
  • If you identify any issues or errors in this content, or if you wish to submit your own ICO project for listing, please contact us via email at info@icoholder.com.
Please read the disclaimer and risk warning. Show disclaimer and risk warning.